Company profile: Lotus Clinical Research
1.1 - Company Overview
Company description
- Provider of full-service CRO services and a network of 20+ wholly-owned US clinical research sites for analgesic programs and trials in psychiatry, neurology, pain, and addiction. Services include project management, site selection and monitoring, EDC and data management, biostatistics, medical monitoring, medical writing, quality operations, placebo response mitigation, global rater training, scientific consultation, and metabolic disease trial support.
Products and services
- Analgesic Experts: Specialized analgesic program services architected to execute placebo response mitigation, global rater training and certification, and clinical development and scientific consultation for acute and chronic pain
- CRO Services: Full-service CRO delivering all clinical phases, covering project management, site selection and monitoring, EDC and data management, biostatistics, medical monitoring, medical writing, and quality operations supporting regulatory submissions
- Network of Sites: 20+ wholly-owned US clinical research sites conducting research in psychiatry, neurology, pain, addiction, and more across diverse therapeutic areas
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Lotus Clinical Research
Rokshaw Laboratories
HQ: United Kingdom
Website
- Description: Provider of family-owned Specials manufacturing, delivering trusted service.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rokshaw Laboratories company profile →
Biomind Labs
HQ: Canada
Website
- Description: Provider of pharmaceutical development for neurological and psychiatric disorders, advancing candidates including BMND01 for treatment-resistant depression, BMND03 for addictive disorders, BMND07 for major depressive disorder, BMND09 for Parkinson’s disease, BMND08 for depression and anxiety in Alzheimer’s disease, and Triptax™, a new chemical entity for treatment-resistant depression with FDA IND clearance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biomind Labs company profile →
Neri Science
HQ: United States
Website
- Description: Provider of customized research and clinical trial solutions to private companies and public-sector organizations, with global reach, experience, long-standing relationships with leading researchers and key institutions around the world, and a proven commitment to state-of-the science research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neri Science company profile →
Phastar
HQ: United Kingdom
Website
- Description: Provider of specialist biometrics contract research services, offering statistical consulting, clinical trial reporting, data management, and data science for clinical trials. Also provides rescue trial support and functional services partnerships via expert consultants, in-house projects, FSP-style arrangements, and preferred partnerships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phastar company profile →
Pharmia
HQ: Finland
Website
- Description: Provider of nutritional supplements and healthcare supplies, developing and manufacturing products and specializing in product development. The company continually innovates, researches, and develops new compositions, flavors, and product applications, serving companies that market food supplements in Finland.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharmia company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Lotus Clinical Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Lotus Clinical Research
2.2 - Growth funds investing in similar companies to Lotus Clinical Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Lotus Clinical Research
4.2 - Public trading comparable groups for Lotus Clinical Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →